Procoagulant activity in bronchoalveolar fluids: No relationship with tissue factor pathway inhibitor activity
- 1 March 1992
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 65 (4-5) , 507-518
- https://doi.org/10.1016/0049-3848(92)90202-l
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Release of extrinsic pathway inhibitor after heparin injection: Increased response in cancer patientsThrombosis Research, 1990
- Asbestos Exposure Results in Increased Lung Procoagulant Activity in Vivo and in VitroChest, 1990
- Depressed Bronchoalveolar Urokinase Activity in Patients with Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1990
- Local activation of the coagulation and fibrinolysis systems in lung diseaseThrombosis Research, 1990
- Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.Journal of Clinical Investigation, 1989
- Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.Thorax, 1988
- Procoagulant and Plasminogen Activator Activities of Bronchoalveolar Fluid in Patients with Pulmonary SarcoidosisExperimental Lung Research, 1988
- A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractionsThrombosis Research, 1987
- Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease.Journal of Clinical Investigation, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976